MAP4343

Research use only, not for human use.

Map4343 is a 3-methyl ether derivative of pregnenolone. Map4343 binds to microtubule associated protein 2 (MAP2) in vitro and stimulates tubulin polymerization, resulting in enhanced neurite extension and protection of neurons from neurotoxic agents.

Map4343 is a 3-methyl ether derivative of pregnenolone. Map4343 binds to microtubule associated protein 2 (MAP2) in vitro and stimulates tubulin polymerization, resulting in enhanced neurite extension and protection of neurons from neurotoxic agents.

MAP4343 (40 μM; 15 or 30 min) stimulates microtubule polymerization in vitro.MAP4343 (30 μM; 2-8 d) stimulates nerve growth factor (NGF)-induced neurite outgrowth in PC12 cells.MAP4343 (20 μM; 1 h) protects against microtubule depolymerization induced by Nocodazole in PC12 cells .

MAP4343 (12 mg/kg; daily s.c. for 28 d) improves the recovery of locomotor function after spinal cord injury (SCI) in rats.MAP4343 (4 mg/kg; daily s.c. for 6 d) increases MAP2 levels in spinal cord after SCI in rats.MAP4343 (4 mg/kg; daily s.c. for 6 d) increases the size of lumbar spinal motoneurons' dendrite arbours after SCI in rats. Animal Model:Adult Sprague-Dawley male rats with spinal cord injuryDosage:12 mg/kg Administration:Daily s.c. for 28 days Result:Increased the number of animals able to walk with weight-supported plantar steps.Showed forelimb-hindlimb coordination at the end of the study.

——

Cytoskeleton/Cell Adhesion Molecules

Microtubule/Tubulin

——

——

——

511-26-2

660

C44H67O4

>98% (HPLC)

In Vitro:?DMSO : 25 mg/mL (75.64 mM)

C[C@](CC1)([C@@H](CC2)[C@H]3[C@H]1[C@@](C)(CC[C@@H](C1)OC)C1=CC3)[C@H]2C(C)=OC[C@](CC1)([C@@H](CC2)[C@H]3[C@H]1[C@@](C)(CC[C@@H](C1)OC)C1=CC3)[C@H]2C(C)=O

——

(-20℃)

With Ice Pack

≥ 2 years